Emcure Pharmaceuticals
FDA Approved Drugs

Emcure Pharmaceuticals

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified RX Discontinued
  • Total Records 23
  • Latest Approval Date Sep 11, 2012
  • Data Source FDA
  • First Approval Date Jul 30, 2007
All
23
View
Unclassified
17
View
Discontinued
4
View
RX
2
View
Company Overview

Company

Emcure Pharmaceuticals

Country

India

Website

Visit Website

Email

corporate@emcure.co.in

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Emcure Pharmaceuticals

M.I.D.C., Hinjawadi, Pune- 411 057

India

www.emcure.com/ corporate@emcure.co.in View on Map
FDA Approved Drug Records ( 23 records )
-
Unclassified Application: 212181

Drug Name

ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

212181 / 1

Active Ingredient

ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

Application Number

212181

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212181

Drug Name

ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

-

212181 / 2

Active Ingredient

ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

Application Number

212181

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212181

Drug Name

ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

-

212181 / 3

Active Ingredient

ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

Application Number

212181

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78785

Drug Name

ATAZANAVIR SULFATE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

78785 / 1

Active Ingredient

ATAZANAVIR SULFATE

Application Number

78785

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78785

Drug Name

ATAZANAVIR SULFATE

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

-

78785 / 2

Active Ingredient

ATAZANAVIR SULFATE

Application Number

78785

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78785

Drug Name

ATAZANAVIR SULFATE

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

-

78785 / 3

Active Ingredient

ATAZANAVIR SULFATE

Application Number

78785

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 200196

Drug Name

ATAZANAVIR SULFATE

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

-

200196 / 1

Active Ingredient

ATAZANAVIR SULFATE

Application Number

200196

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205508

Drug Name

ATAZANAVIR SULFATE; RITONAVIR

Product Number

1

Dosage Form

-

Strength

300MG; 100MG

Approval Date

-

205508 / 1

Active Ingredient

ATAZANAVIR SULFATE; RITONAVIR

Application Number

205508

Product Number

1

Dosage Form

-

Strength

300MG; 100MG

Approval Date

-

Regulatory Status

Unclassified

2007
30 Jul
RX Application: 40682

Drug Name

BENZONATATE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2007-07-30

40682 / 1

Active Ingredient

BENZONATATE

Application Number

40682

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2007-07-30

Regulatory Status

RX

2007
30 Jul
RX Application: 40682

Drug Name

BENZONATATE

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2007-07-30

40682 / 2

Active Ingredient

BENZONATATE

Application Number

40682

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2007-07-30

Regulatory Status

RX

-
Unclassified Application: 219623

Drug Name

DOLUTEGRAVIR AND LAMIVUDINE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

-

219623 / 2

Active Ingredient

DOLUTEGRAVIR AND LAMIVUDINE

Application Number

219623

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211868

Drug Name

DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Product Number

1

Dosage Form

-

Strength

50MG/300MG/300MG

Approval Date

-

211868 / 1

Active Ingredient

DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Application Number

211868

Product Number

1

Dosage Form

-

Strength

50MG/300MG/300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78958

Drug Name

EFAVIRENZ

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

-

78958 / 1

Active Ingredient

EFAVIRENZ

Application Number

78958

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

-

Regulatory Status

Unclassified

2012
11 Sep
Discontinued Application: 202063

Drug Name

GEMCITABINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 200MG BASE/VIAL

Approval Date

2012-09-11

202063 / 1

Active Ingredient

GEMCITABINE HYDROCHLORIDE

Application Number

202063

Product Number

1

Dosage Form

-

Strength

EQ 200MG BASE/VIAL

Approval Date

2012-09-11

Regulatory Status

Discontinued

2012
11 Sep
Discontinued Application: 202063

Drug Name

GEMCITABINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2012-09-11

202063 / 2

Active Ingredient

GEMCITABINE HYDROCHLORIDE

Application Number

202063

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2012-09-11

Regulatory Status

Discontinued

2012
14 Feb
Discontinued Application: 200771

Drug Name

IRINOTECAN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

40MG/2ML (20MG/ML)

Approval Date

2012-02-14

200771 / 1

Active Ingredient

IRINOTECAN HYDROCHLORIDE

Application Number

200771

Product Number

1

Dosage Form

-

Strength

40MG/2ML (20MG/ML)

Approval Date

2012-02-14

Regulatory Status

Discontinued

2012
14 Feb
Discontinued Application: 200771

Drug Name

IRINOTECAN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

100MG/5ML (20MG/ML)

Approval Date

2012-02-14

200771 / 2

Active Ingredient

IRINOTECAN HYDROCHLORIDE

Application Number

200771

Product Number

2

Dosage Form

-

Strength

100MG/5ML (20MG/ML)

Approval Date

2012-02-14

Regulatory Status

Discontinued

-
Unclassified Application: 200771

Drug Name

IRINOTECAN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

100MG/5ML

Approval Date

-

200771 / 3

Active Ingredient

IRINOTECAN HYDROCHLORIDE

Application Number

200771

Product Number

3

Dosage Form

-

Strength

100MG/5ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78929

Drug Name

LAMIVUDINE; ZIDOVUDINE

Product Number

1

Dosage Form

-

Strength

150MG; 300MG

Approval Date

-

78929 / 1

Active Ingredient

LAMIVUDINE; ZIDOVUDINE

Application Number

78929

Product Number

1

Dosage Form

-

Strength

150MG; 300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78887

Drug Name

NEVIRAPINE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

-

78887 / 1

Active Ingredient

NEVIRAPINE

Application Number

78887

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78587

Drug Name

STAVUDINE

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

-

78587 / 1

Active Ingredient

STAVUDINE

Application Number

78587

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22342

Drug Name

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Product Number

1

Dosage Form

-

Strength

30MG; 150MG; 200MG

Approval Date

-

22342 / 1

Active Ingredient

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Application Number

22342

Product Number

1

Dosage Form

-

Strength

30MG; 150MG; 200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22342

Drug Name

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Product Number

2

Dosage Form

-

Strength

40MG; 150MG; 200MG

Approval Date

-

22342 / 2

Active Ingredient

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Application Number

22342

Product Number

2

Dosage Form

-

Strength

40MG; 150MG; 200MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    22 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    23 View
Drug Status Breakdown
23 total
  • Unclassified
  • RX
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

Application Number

212181

Product Number

1

Active Ingredient

ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

Dosage Form

-

Strength

50MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit